YUNNAN BAIYAO GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.11 CNY | +0.43% |
|
+2.33% | +10.09% |
| Jun. 06 | Yuyue Medical Owners Prohibited from Leaving China for Alleged Links to Baiyao Corruption Case | MT |
| May. 13 | Yunnan Baiyao's Unit to Conduct Clinical Trials on Prostate Cancer Drug | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 113,943 | 144,813 | 134,227 | 96,993 | 87,697 | 96,546 | - | - |
| Enterprise Value (EV) 1 | 101,865 | 132,453 | 117,268 | 85,883 | 75,302 | 80,113 | 81,962 | 81,286 |
| P/E ratio | 27.3 x | 26.4 x | 48 x | 28.6 x | 21.5 x | 20.9 x | 19.2 x | 17.3 x |
| Yield | 3.35% | 3.43% | 1.53% | 2.8% | 4.23% | 3.66% | 4.19% | 4.54% |
| Capitalization / Revenue | 3.84 x | 4.42 x | 3.69 x | 2.66 x | 2.24 x | 2.28 x | 2.11 x | 1.98 x |
| EV / Revenue | 3.43 x | 4.05 x | 3.22 x | 2.35 x | 1.93 x | 1.89 x | 1.79 x | 1.66 x |
| EV / EBITDA | 20.7 x | 31 x | 24.8 x | 22.9 x | 14.8 x | 14.3 x | 13.8 x | 12.6 x |
| EV / FCF | 76.3 x | 39.4 x | 25 x | 31 x | - | 18.4 x | 16.7 x | 14.3 x |
| FCF Yield | 1.31% | 2.54% | 4% | 3.22% | - | 5.44% | 5.98% | 7.01% |
| Price to Book | 3.01 x | 3.81 x | 3.51 x | 2.54 x | 2.21 x | 2.32 x | 2.26 x | 2.17 x |
| Nbr of stocks (in thousands) | 1,783,743 | 1,784,666 | 1,795,682 | 1,784,263 | 1,784,263 | 1,784,263 | - | - |
| Reference price 2 | 63.88 | 81.14 | 74.75 | 54.36 | 49.15 | 54.11 | 54.11 | 54.11 |
| Announcement Date | 3/26/20 | 3/26/21 | 3/25/22 | 3/30/23 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 29,665 | 32,743 | 36,374 | 36,488 | 39,111 | 42,421 | 45,712 | 48,884 |
| EBITDA 1 | 4,920 | 4,274 | 4,724 | 3,744 | 5,103 | 5,605 | 5,931 | 6,460 |
| EBIT 1 | 4,743 | 6,812 | 3,485 | 3,371 | 4,831 | 5,175 | 5,608 | 6,218 |
| Operating Margin | 15.99% | 20.8% | 9.58% | 9.24% | 12.35% | 12.2% | 12.27% | 12.72% |
| Earnings before Tax (EBT) 1 | 4,726 | 6,801 | 3,482 | 3,377 | 4,818 | 5,510 | 5,968 | 6,623 |
| Net income 1 | 4,184 | 5,516 | 2,804 | 3,001 | 4,094 | 4,639 | 5,051 | 5,606 |
| Net margin | 14.1% | 16.85% | 7.71% | 8.22% | 10.47% | 10.94% | 11.05% | 11.47% |
| EPS 2 | 2.343 | 3.079 | 1.557 | 1.900 | 2.290 | 2.589 | 2.819 | 3.126 |
| Free Cash Flow 1 | 1,334 | 3,358 | 4,694 | 2,767 | - | 4,357 | 4,901 | 5,697 |
| FCF margin | 4.5% | 10.26% | 12.9% | 7.58% | - | 10.27% | 10.72% | 11.65% |
| FCF Conversion (EBITDA) | 27.12% | 78.56% | 99.36% | 73.91% | - | 77.74% | 82.64% | 88.18% |
| FCF Conversion (Net income) | 31.9% | 60.88% | 167.41% | 92.19% | - | 93.91% | 97.03% | 101.62% |
| Dividend per Share 2 | 2.143 | 2.786 | 1.143 | 1.520 | 2.077 | 1.979 | 2.268 | 2.456 |
| Announcement Date | 3/26/20 | 3/26/21 | 3/25/22 | 3/30/23 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | 9,797 | 9,379 | 9,423 | 10,774 | 10,645 | 10,191 | 10,239 | 12,036 | 11,216 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | - | - | - | - | - | 1,583 | 1,560 | -42.87 | 1,918 | 1,515 | 1,257 | -26.41 | - | - |
| Operating Margin | - | - | - | - | - | - | 16.16% | 16.63% | -0.45% | 17.8% | 14.24% | 12.33% | -0.26% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 1,576 | 1,560 | -45.75 | 1,920 | 1,805 | 1,710 | 96.04 | - | - |
| Net income 1 | - | - | - | - | - | - | 1,310 | 1,295 | -29.7 | 1,702 | 1,489 | 1,395 | 102.1 | - | - |
| Net margin | - | - | - | - | - | - | 13.37% | 13.81% | -0.32% | 15.8% | 13.99% | 13.68% | 1% | - | - |
| EPS 2 | 0.1929 | 0.5071 | 0.3800 | 0.4300 | 0.3800 | 0.8500 | 0.7300 | 0.7200 | -0.0100 | 0.9500 | 0.5200 | 0.7700 | 0.8100 | 1.020 | 0.8800 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | 2.077 | - | - | - | 2.281 | - | - |
| Announcement Date | 3/25/22 | 4/28/22 | 8/29/22 | 10/27/22 | 3/30/23 | 4/26/23 | 8/29/23 | 10/30/23 | 3/29/24 | 4/26/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 12,078 | 12,360 | 16,959 | 11,109 | 12,394 | 16,433 | 14,585 | 15,261 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 1,334 | 3,358 | 4,694 | 2,767 | - | 4,357 | 4,901 | 5,697 |
| ROE (net income / shareholders' equity) | 10.3% | 14.5% | 7.58% | 7.87% | 10.5% | 11.4% | 12% | 12.9% |
| ROA (Net income/ Total Assets) | 8.08% | 10.5% | 5.22% | 5.68% | 7.64% | 8.36% | 8.59% | 8.95% |
| Assets 1 | 51,804 | 52,439 | 53,757 | 52,807 | 53,553 | 55,495 | 58,830 | 62,637 |
| Book Value Per Share 2 | 21.20 | 21.30 | 21.30 | 21.40 | 22.20 | 23.30 | 23.90 | 24.90 |
| Cash Flow per Share 2 | 1.180 | 2.140 | 2.910 | 1.790 | 1.950 | 1.750 | 2.180 | 2.330 |
| Capex 1 | 770 | 471 | 530 | 443 | 575 | 346 | 400 | 408 |
| Capex / Sales | 2.6% | 1.44% | 1.46% | 1.21% | 1.47% | 0.82% | 0.88% | 0.84% |
| Announcement Date | 3/26/20 | 3/26/21 | 3/25/22 | 3/30/23 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
54.11
CNY
Average target price
65.01
CNY
Spread / Average Target
+20.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.09% | 13.32B | |
| +45.82% | 765B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.85% | 248B | |
| -1.72% | 219B | |
| +11.10% | 216B | |
| +5.90% | 164B | |
| -0.73% | 162B |
- Stock Market
- Equities
- 000538 Stock
- Financials Yunnan Baiyao Group Co.,Ltd
